Longitudinal and noninvasive assessment of emphysema evolution in a murine model using proton MRI

Magdalena Zurek1, Laurent Boyer, Philippe Caramelle

  • 1Université de Lyon, CREATIS-LRMN, Lyon, France.

Insights

Ultrashort echo time MRI effectively tracks emphysema progression in mice lungs by monitoring signal intensity and T2 changes. This non-invasive imaging method correlates well with histology, aiding drug therapy assessment.

Area of Science:

  • Biomedical Imaging
  • Pulmonary Research
  • Preclinical Disease Modeling

Background:

  • Emphysema is a progressive lung disease characterized by alveolar destruction.
  • Accurate longitudinal monitoring of emphysema development is crucial for therapeutic evaluation.
  • Current methods may lack the sensitivity or resolution for early-stage detection.

Purpose of the Study:

  • To evaluate ultrashort echo time (550 μs) MRI for tracking emphysema progression in a mouse model.
  • To assess the utility of signal intensity and T2 relaxation time as quantitative biomarkers.
  • To determine the correlation between MRI findings and histological emphysema severity.

Main Methods:

  • Elastase was used to induce emphysema in nine mice, with five saline-instilled mice serving as controls.
  • Mice were imaged using ultrashort echo time MRI at baseline, 24 hours, 3 weeks, and 8 weeks post-instillation.
  • Signal intensity and T2 values were quantified and compared between groups and correlated with histological data.

Main Results:

  • Emphysematous mice showed significantly lower normalized signal intensity (0.64 ± 0.10 vs 0.89 ± 0.20) and T2 values (0.96 ± 0.18 ms vs 1.27 ± 0.35 ms) at 8 weeks compared to controls.
  • These changes were prominent by 3 weeks and stabilized thereafter.
  • MRI parameters demonstrated excellent agreement with histological morphometry (r = -0.78 for both).

Conclusions:

  • Ultrashort echo time proton MRI is a valuable tool for longitudinal monitoring of structural changes in emphysema at the alveolar level.
  • Signal intensity and T2 relaxation time serve as reliable biomarkers for disease progression.
  • This technique holds promise for routine application in preclinical trials to assess the efficacy of emphysema therapies.

Related Concept Videos